Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Education
  • General

If You Invested $1,000 In The U.S. Oil ETF At Its COVID-19 Pandemic Low, Here’s How Much You’d Have Now

By Wayne Duggan
July 18, 3:32 PM
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some investments performed better than others along the way.

USO

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Price Target
  • Small Cap

HC Wainwright Is Bullish On DICE Therapeutics – Read Why

By Vandana Singh
July 18, 3:31 PM
H.C. Wainwright analyst Emily Bodnar initiated coverage on DICE Therapeutics Inc (NASDAQ:DICE) with a Buy rating and a price target of $40 (150%…

AMGN

Read More
1 minute read
  • General
  • Management
  • News

Tractor Supply Taps New Marketing Chief

By Shivani Kumaresan
July 18, 3:12 PM
Tractor Supply Co (NASDAQ:TSCO) has appointed Kimberley Gardiner as Senior Vice President and Chief Marketing Officer (CMO). Gardiner succeeds Christi Korzekwa,…

TSCO

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Small Cap
  • Trading Ideas

HC Wainwright Initiates Coverage On This Nanocrystals Stock

By Vandana Singh
July 18, 3:05 PM
H.C. Wainwright initiated coverage on Clene Inc (NASDAQ:CLNN) with a Buy rating and a $16 price target.  Clene is focused on the…

CLNN

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • News

Nestle Bets €40M On Enterome’s Preclinical Food Allergy, IBD Hopeful

By Vandana Singh
July 18, 2:59 PM
France-based Enterome signed a strategic R&D collaboration and license agreement with Nestlé SA’s (OTC:NSRGF) Health Science, targeting food allergies and inflammatory bowel disease…

NSRGF

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Health Care
  • Initiation
  • News
  • Price Target

With Sustained Double-Digit Growth Profile, RBC Starts Coverage On This MedTech Stock

By Vandana Singh
July 18, 2:56 PM
RBC Capital Markets initiated coverage on Penumbra Inc (NYSE:PEN) with an Outperform rating and a price target of $195 (59% implied upside).…

PEN

Read More
1 minute read
  • General
  • M&A
  • News
  • Penny Stocks

Elektros Eyes Major Stake In Arizona Solar Power Energy

By Shivani Kumaresan
July 18, 2:53 PM
Elektros Inc (OTC:ELEK) has signed a Letter of Intent to purchase 60% of Arizona Solar Power Energy Inc. Elektros intends to tap…

ELEK

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • Downgrades
  • General
  • Health Care
  • News
  • Penny Stocks

HC Wainwright Downgrades Angion Biomedica

By Vandana Singh
July 18, 2:53 PM
Last month, Angion Biomedica Corp (NASDAQ:ANGN) discontinued the JUNIPER Phase 2 dose-finding trial of ANG-3070 in primary proteinuric kidney diseases, specifically focal…

ANGN

Read More
1 minute read
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Initiation
  • News
  • Small Cap

SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside

By Vandana Singh
July 18, 2:46 PM
SVB Leerink initiated coverage on Nkarta Inc (NASDAQ:NKTX) with an Outperform rating and a price target of $30 (117% implied upside). The…

NKTX

Read More
1 minute read
  • General
  • Politics

West Virginia Judge Blocks Enforcement Of Pre-Roe V. Wade State Abortion Ban From 19th Century

By Bill Haddad
July 18, 2:38 PM
-Reuters

SPY

Posts pagination

Previous 1 … 2,319 2,320 2,321 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service